LewisJRubinMD
Pulmonology • La Jolla, CACritical Care Medicine, Pleural Disease
Professor of Medicine, UCSD
Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5550 Caminito Genio
La Jolla, CA 92037Phone+1 858-736-7542- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1979- Duke University HospitalResidency, Internal Medicine, 1975 - 1978
Albert Einstein College of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 2015 - 2024
MD State Medical License 1985 - 2017
NC State Medical License 1978 - 2017
CA State Medical License 1999 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Clinical Trials
- ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2004 Jan 01
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 1 citationsSotatercept for pulmonary arterial hypertension: something old and something new.Lewis J Rubin, Robert Naeije> ;The European Respiratory Journal. 2023 Jan 1
- Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension Program.Vallerie V McLaughlin, Richard N Channick, Karimah S Bell Lynum, Ronald J Oudiz, Mona Selej, Victor F Tapson, Lewis J Rubin> ;Pulmonary Circulation. 2022 Jul 1
- 16 citationsThe impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.Stephan Rosenkranz, Richard N. Channick, Kelly Chin, Bartosz Jenner, Sean Gaine, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Vallerie V. McLaughlin,...> ;European Journal of Heart Failure. 2021 Nov 21
- Join now to see all
Other
- Overview of pulmonary hypertension in adultsRubin LJ, Hopkins W
http://www.uptodate.com/contents/overview-of-pulmonary-hypertension-in-adults
UpToDate, Wolters Kluwer Health - 2013-04-12 - Clinical features and diagnosis of pulmonary hypertension in adultsRubin LJ, Hopkins W
http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-pulmonary-hypertension-in-adults
UpToDate, Wolters Kluwer Health - 2012-12-13 - Pathogenesis of pulmonary hypertensionRubin LJ, Hopkins W
http://www.uptodate.com/contents/pathogenesis-of-pulmonary-hypertension
UpToDate, Wolters Kluwer Health - 2012-10-22 - Join now to see all
Press Mentions
Karos Pharmaceuticals Advances Development of KAR5585 to Treat Pulmonary Arterial Hypertension into the ClinicApril 13th, 2016
Pulmonary Hypertension Association (PHA) Names ‘Periwinkle Pioneers’: Honor Recognizes 25 Years of Pulmonary Hypertension (PH) AdvancementsNovember 25th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
